Sargent Investment Group, LLC Coherus Bio Sciences, Inc. Transaction History

Sargent Investment Group, LLC

  • $616 Million
  • Q4 2024

A detailed history of Sargent Investment Group, LLC transactions in Coherus Bio Sciences, Inc. stock. As of the latest transaction made, Sargent Investment Group, LLC holds 24,285 shares of CHRS stock, worth $25,984. This represents 0.01% of its overall portfolio holdings.

Number of Shares
24,285
Previous 43,130 43.69%
Holding current value
$25,984
Previous $44,000 25.0%
% of portfolio
0.01%
Previous 0.01%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 27, 2025
SELL
$0.67 - $1.71 $12,626 - $32,224
-18,845 Reduced 43.69%
24,285 $33,000
Q2 2024

Aug 09, 2024
SELL
$1.58 - $2.51 $8,800 - $13,980
-5,570 Reduced 11.44%
43,130 $74,000
Q1 2024

May 10, 2024
BUY
$2.02 - $3.14 $45,732 - $71,089
22,640 Added 86.88%
48,700 $116,000
Q4 2023

Feb 05, 2024
BUY
$1.59 - $3.85 $10,125 - $24,516
6,368 Added 32.34%
26,060 $86,000
Q2 2023

Jul 31, 2023
BUY
$3.79 - $8.3 $74,632 - $163,443
19,692 New
19,692 $84,000
Q4 2022

Jan 31, 2023
SELL
$5.69 - $10.07 $22,589 - $39,977
-3,970 Reduced 26.17%
11,200 $88,000
Q3 2022

Oct 26, 2022
SELL
$7.17 - $13.87 $45,565 - $88,143
-6,355 Reduced 29.52%
15,170 $148,000
Q2 2022

Jul 26, 2022
SELL
$5.86 - $13.23 $29,915 - $67,539
-5,105 Reduced 19.17%
21,525 $156,000
Q1 2022

May 06, 2022
SELL
$10.92 - $16.41 $143,095 - $215,036
-13,104 Reduced 32.98%
26,630 $344,000
Q4 2021

Feb 11, 2022
SELL
$15.81 - $18.99 $107,602 - $129,245
-6,806 Reduced 14.62%
39,734 $634,000
Q3 2021

Nov 12, 2021
SELL
$12.68 - $17.79 $649,152 - $910,759
-51,195 Reduced 52.38%
46,540 $748,000
Q2 2021

Aug 05, 2021
SELL
$12.95 - $15.41 $87,386 - $103,986
-6,748 Reduced 6.46%
97,735 $1.35 Million
Q1 2021

May 04, 2021
BUY
$14.42 - $21.39 $97,176 - $144,147
6,739 Added 6.89%
104,483 $1.53 Million
Q4 2020

Feb 10, 2021
SELL
$16.56 - $18.94 $134,003 - $153,262
-8,092 Reduced 7.65%
97,744 $1.7 Million
Q3 2020

Nov 12, 2020
BUY
$17.41 - $19.89 $255,160 - $291,507
14,656 Added 16.07%
105,836 $1.94 Million
Q2 2020

Aug 11, 2020
BUY
$14.43 - $19.16 $137,157 - $182,115
9,505 Added 11.64%
91,180 $1.66 Million
Q1 2020

May 12, 2020
BUY
$11.67 - $22.53 $203,291 - $392,472
17,420 Added 27.11%
81,675 $1.33 Million
Q4 2019

Jan 30, 2020
BUY
$16.33 - $21.37 $371,017 - $485,526
22,720 Added 54.7%
64,255 $1.16 Million
Q3 2019

Oct 29, 2019
BUY
$16.3 - $23.37 $406,196 - $582,380
24,920 Added 149.98%
41,535 $841,000
Q2 2019

Aug 12, 2019
BUY
$13.1 - $22.1 $217,656 - $367,191
16,615 New
16,615 $367,000

Others Institutions Holding CHRS

# of Institutions
130
Shares Held
67.8M
Call Options Held
1.68M
Put Options Held
91.8K
View Full List

About Coherus BioSciences, Inc.

CHRS Quotes by TradingView
  • Ticker CHRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 77,724,600
  • Market Cap $83.2M
  • Description
  • Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...
More about CHRS
Track This Portfolio

Track Sargent Investment Group, LLC Portfolio

Follow Sargent Investment Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sargent Investment Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sargent Investment Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email